A meta-analytic comparison of preoperative stress echocardiography and nuclear scintigraphy imaging

Anesthesia and Analgesia

Volumn 102, Issue 1, 2006, Pages 8-16

  Beattie, W Scott ^a,b   Abdelnaem, Esam ^b   Wijeysundera, Duminda N ^b   Norman Buckley, D ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b Department of Clinical Research and Preventive Assessment ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ATROPINE; DIPYRIDAMOLE; DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM;

ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEART INFARCTION; HEART PERFUSION; HEART SCINTISCANNING; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MORTALITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STRESS ECHOCARDIOGRAPHY; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 29844436330     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000189614.98906.43     Document Type: Article

References (94)

1. Detsky AS, Abrams HB, Forbath N, et al. Cardiac assessment for patients undergoing noncardiac surgery: a multifactorial clinical risk index. Arch Intern Med 1986;146:2131-4.
2. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-9.
3. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297;845-50.
4. Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989;110:859-66.
5. Mantha S, Roizen MF, Barnard J, et al. Relative effectiveness of four preoperative tests for predicting adverse cardiac outcomes after vascular surgery: a meta-analysis. Anesth Analg 1994;79:422-33.
6. Shaw LJ, Eagle KA, Gersh BJ, Miller DD. Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol 1996;27:787-98.
7. Rabbat CG, Treleaven DJ, Russell JD, et al. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J Am Soc Nephrol 2003;14:431-9.
8. Etchells E, Meade M, Tomlinson G, Cook D. Semiquantitative dipyridamole myocardial stress perfusion imaging for cardiac risk assessment before noncardiac vascular surgery: a meta-analysis. J Vasc Surg 2002;36:534-40.
9. Kertai MD, Boersma E, Bax JJ, et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 2003;89:1327-34.
10. Devereaux PJ, Beattie WS, Choi P, et al. How strong is the evidence for the use of perioperative beta-blockers in non-cardiac surgery? Systematic review and meta-analysis of randomized controlled trials. BMJ 2005;1136:313-21.
11. Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005;353:349-61.
12. McFalls EO, Ward HB, Moritz TE, et al. Coronary artery revascularization before elective major vascular surgery. The CARP Trial. N Engl J Med 2005;351:2795-804.
13. Pepe MS, Janes H, Longton G, et al. Limitations in odds ratio in gauging the performance of a diagnostic, prognostic or screening marker. Am J Epidemiol 2000;159:882-90.
14. Irwig L, Macaskill P, Glasziou P, Fahey M. Meta-analytic methods for diagnostic test accuracy. J Clin Epidemiol 1995;48:119-30.
15. Walter SD, Irwig L, Glasziou PP. Meta-analysis of diagnostic tests with imperfect reference standards. J Clin Epidemiol 1999;52:943-51.
16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
17. Higgins J, Thompson SG. Quantifying heterogeneity in meta-analysis. Stat Med 2002;21:1539-58.
18. Van Damme H, Pierard L, Gillain D, et al. Cardiac risk assessment before vascular surgery: a prospective study comparing clinical evaluation, dobutamine stress echocardiography, and dobutamine Tc-99m sestamibi tomoscintigraphy. Cardiovasc Surg 1997;5:54-64.
19. Davila-Roman VG, Waggoner AD, Sicard GA, et al. Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease. J Am Coll Cardiol 1993;21:957-03.
20. Ballal RS, Kapadia S, Secknus MA, et al. Prognosis of patients with vascular disease after clinical evaluation and dobutamine stress echocardiography. Am Heart J 1999;137:469-75.
21. Tischler MD, Lee TH, Hirsch AT, et al. Prediction of major cardiac events after peripheral vascular surgery using dipyridamole echocardiography. Am J Cardiol 1991;68:593-7.
22. Plotkin JS, Johnson LB, Rustgi VK, et al. Dobutamine stress echocardiography for orthotopic liver transplant evaluation. Transplantation 2001;71:818.
23. Bossone E, Martinez FJ, Whyte RI, et al. Dobutamine stress echocardiography for the preoperative evaluation of patients undergoing lung volume reduction surgery. J Thorac Cardiovasc Surg 1999;118:542-6.
24. Torres MR, Short L, Baglin T, et al. Usefulness of clinical risk markers and ischemic threshold to stratify risk in patients undergoing major noncardiac surgery. Am J Cardiol 2002;90:238-42.
25. Langan EM, Youkey JR, Franklin DP, et al. Dobutamine stress echocardiography for cardiac risk assessment before aortic surgery. J Vasc Surg 1993;18:905-11.
26. Day SM, Younger JG, Karavite D, et al. Usefulness of hypotension during dobutamine echocardiography in predicting perioperative cardiac events. Am J Cardiol 2000;85:478-83.
27. Das MK, Pellikka PA, Mahoney DW, et al. Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients. J Am Coll Cardiol 2000;35:1647-53.
28. Lalka SG, Sawada SG, Dalsing MC, et al. Dobutamine stress echocardiography as a predictor of cardiac events associated with aortic surgery. J Vasc Surg 1992;15:831-40.
29. Sicari R, Ripoli A, Picano E, et al. Perioperative prognostic value of dipyridamole echocardiography in vascular surgery: a large-scale multicenter study in 509 patients. EPIC (Echo Persantine International Cooperative) Study Group. Circulation 1999;100: II269-74.
30. Pasquet A, D'hondt AM, Verhelst R, et al. Comparison of dipyridamole stress echocardiography and perfusion scintigraphy for cardiac risk stratification in vascular surgery patients. Am J Cardiol 1998;82:1468-74.
31. Mocini D, Uguccioni M, Galli C, et al. Dipyridamole echocardiography and 99mTc-MIBI spect dipyridamole scintigraphy for cardiac evaluation prior to peripheral vascular surgery. Minerva Cardioangiol 1995;43:185-90.
32. Rossi E, Citterio F, Vescio MF, et al. Risk stratification of patients undergoing peripheral vascular revascularization by combined resting and dipyridamole echocardiography. Am J Cardiol 1998;82:306-10.
33. Shafritz R, Ciocca RG, Gosin JS, et al. The utility of dobutamine echocardiography in preoperative evaluation for elective aortic surgery. Am J Surg 1997;174:121-5.
34. Mondillo S, Ballo P, Agricola E, et al. Noninvasive tests for risk stratification in major vascular surgery. Vasa 2002;31:195-201.
35. Kontos MC, Akosah KO, Brath LK, et al. Cardiac complications in noncardiac surgery: value of dobutamine stress echocardiography versus dipyridamole thallium imaging. J Cardiothorac Vasc Anesth 1996;10:329-35.
36. Zamorano J, Duque A, Baquero M, et al. Stress echocardiography in the pre-operative evaluation of patients undergoing major vascular surgery: are results comparable with dipiridamole versus dobutamine stress echo? Rev Esp Cardiol 2002;55:121-6.
37. Lacroix H, Herregod MC, Ector H, et al. The value of dipyridamole thallium scintigraphy and dobutamine stress echocardiography as predictors of cardiac complications following reconstruction of the abdominal aorta. Int Angiol 2000;19:231-6.
38. Eichelberger JP, Schwarz KQ, Black ER, et al. Predictive value of dobutamine echocardiography just before noncardiac vascular surgery. Am J Cardiol 1993;72:602-7.
39. Poldermans D, Arnese M, Fioretti PM, et al. Sustained prognostic value of dobutamine stress echocardiography for late cardiac events after major noncardiac vascular surgery. Circulation 1997;95:53-8.
40. Boersma E, Poldermans D, Bax JJ, et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2001;285:1865-73.
41. Lane RT, Sawada SG, Segar DS, et al. Dobutamine stress echocardiography for assessment of cardiac risk before noncardiac surgery. Am J Cardiol 1991;68:976-7.
42. Lin K, Stewart D, Cooper S, Davis CL. Pre-transplant cardiac testing for kidney-pancreas transplant candidates and association with cardiac outcomes. Clin Transplant 2001;15:269-75.
43. Boucher CA, Brewster DC, Darling RC, et al. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med 1985;312:389-94.
44. Levinson JR, Boucher CA, Coley CM, et al. Usefulness of semi-quantitative analysis of dipyridamole-thallium-201 redistribution for improving risk stratification before vascular surgery. Am J Cardiol 1990;66:406-10.
45. Marshall ES, Raichlen JS, Forman S, et al. Adenosine radionuclide perfusion imaging in the preoperative evaluation of patients undergoing peripheral vascular surgery. Am J Cardiol 1995;76:817-21.
46. Younis LT, Aguirre F, Byers S, et al. Perioperative and long-term prognostic value of intravenous dipyridamole thallium scintigraphy in patients with peripheral vascular disease. Am Heart J 1990;119:1287-92.
47. Coley CM, Field TS, Abraham SA, et al. Usefulness of dipyridamole- thallium scanning for preoperative evaluation of cardiac risk for nonvascular surgery. Am J Cardiol 1992;69:1280-5.
48. Marwick TH, Shan K, Go RT, et al. Use of positron emission tomography for prediction of perioperative and late cardiac events before vascular surgery. Am Heart J 1995;130:1196-202.
49. Shaw L, Miller DD, Kong BA, et al. Determination of perioperative cardiac risk by adenosine thallium-201 myocardial imaging. Am Heart J 1992;124:861-9.
50. Kresowik TF, Bower TR, Garner SA, et al. Dipyridamole thallium imaging in patients being considered for vascular procedures. Arch Surg 1993;128:299-302.
51. McEnroe CS, O'Donnel TF, Yeager A, et al. Comparison of ejection fraction and Goldman risk factor analysis to dipyridamole-thallium 201 studies in the evaluation of cardiac morbidity after aortic aneurysm surgery. J Vasc Surg 1990;11:497-504.
52. Hendel RC, Chen MH, L'Italien GJ, et al. Sex differences in perioperative and long-term cardiac event-free survival in vascular surgery patients: an analysis of clinical and scintigraphic variables. Circulation 1995;91:1044-51.
53. Huang Z, Komori S, Sawanobori T, et al. Dipyridamole thallium-201 single-photon emission computed tomography for prediction of perioperative cardiac events in patients with arteriosclerosis obliterans undergoing vascular surgery. Jpn Circ J 1998;62:274-8.
54. Baron JF, Mundler O, Bertrand M, et al. Dipyridamole-thallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med 1994;330:663-9.
55. Fletcher JP, Antico VF, Gruenewald S, Kershaw LZ. Dipyridamole-thallium scan for screening of coronary artery disease prior to vascular surgery. J Cardiovasc Surg (Torino) 1988;29:666-9.
56. Kontos MC, Brath LK, Akosah KO, Mohanty PK. Cardiac complications in noncardiac surgery: relative value of resting two-dimensional echocardiography and dipyridamole thallium imaging. Am Heart J 1996;132:559-66.
57. Ombrellaro MP, Dieter RA, Freeman M, et al. Role of dipyridamole myocardial scintigraphy in carotid artery surgery. J Am Coll Surg 1995;181:451-8.
58. Seeger JM, Rosenthal GR, Self SB, et al. Does routine stress-thallium cardiac scanning reduce postoperative cardiac complications? Ann Surg 1994;219:654-61.
59. Stratmann HG, Younis LT, Wittry MD, et al. Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery, prognostic value for perioperative and late cardiac events. Am Heart J 1996;131:923-9.
60. Nguyen TT, Amsterdam EA, Schaefer S. Risk stratification prior to vascular surgery: does the location of a dipyridamole thallium scintigram defect provide prognostic information? Cardiology 1997;88:569-75.
61. Strawn DJ, Guernsey JM. Dipyridamole thallium scanning in the evaluation of coronary artery disease in elective abdominal aortic surgery. Arch Surg 1991;126:880-4.
62. Vandenberg BF, Rossen JD, Grover-McKay M, et al. Evaluation of diabetic patients for renal and pancreas transplantation: non-invasive screening for coronary artery disease using radionuclide methods. Transplantation 1996;62:1230-5.
63. Sachs RN, Tellier P, Larmignat P, et al. Assessment by dipyridamole-thallium-201 myocardial scintigraphy of coronary risk before peripheral vascular surgery. Surgery 1988;103:584-7.
64. Zarich SW, Cohen MC, Lane SE, et al. Routine perioperative dipyridamole 201Tl imaging in diabetic patients undergoing vascular surgery. Diabetes Care 1996;19:355-60.
65. Bry JD, Belkin M, O'Donnell TF, et al. An assessment of the positive predictive value and cost-effectiveness of dipyridamole myocardial scintigraphy in patients undergoing vascular surgery. J Vasc Surg 1994;19:112-21.
66. Mangano DT, London MJ, Tubau JF, et al. Dipyridamole thallium-201 scintigraphy as a preoperative screening test; a reexamination of its predictive potential. Study of Perioperative Ischemia Research Group. Circulation 1991;84:493-502.
67. DeVirgillio C, Pak S, Arnell T, et al. Cardiac assessment prior to vascular surgery: is dipyridamole-sestamibi necessary? Ann Vasc Surg 1996;10:325-9.
68. DeVirgillio C, Toosie K, Elbassir M, et al. Dipyridamole-thallium/ sestamibi before vascular surgery: a prospective blinded study in moderate-risk patients. J Vasc Surg 2000;32:77-89.
69. Vanzetto G, Machecourt J, Blendea D, et al. Additive value of thallium single-photon emission computed tomography myocardial imaging for prediction of perioperative events in clinically selected high cardiac risk patients having abdominal aortic surgery. Am J Cardiol 1996;77:143-8.
70. Vanzetto G, Sessa C, Magne JL, et al. Evaluation of a clinical and scintigraphic management strategy for cardiac risk before abdominal aorta surgery. Apropos of 982 surgical patients [in French]. Arch Mal Coeur Vaiss 1999;92:211-8.
71. Vaquette B, Clergues F, Kalangos A, et al. Prognostic value of thallium 201 myocardial scintigraphy with dipyridamole before peripheral arterial surgery [in French]. Arch Mal Coeur Vaiss 2003;96:281-7.
72. Watters TA, Botvinick EH, Dae MW, et al. Comparison of the findings on preoperative dipyridamole perfusion scintigraphy and intraoperative transesophageal echocardiography: implications regarding the identification of myocardium at ischemic risk. J Am Coll Cardiol 1991;18:93-100.
73. Erickson CA, Carballo RE, Freischlag JA, et al. Using dipyridamole-thallium imaging to reduce cardiac risk in aortic reconstruction. J Surg Res 1996;60:422-8.
74. Roghi A, Palmieri B, Crivellaro W, et al. Preoperative assessment of cardiac risk in noncardiac major vascular surgery. Am J Cardiol 1999;83:169-74.
75. Hashimoto J, Suzuki T, Nakahara T, et al. Preoperative risk stratification using stress myocardial perfusion scintigraphy with electrocardiographic gating. J Nucl Med 2003;44:385-90.
76. Chen T, Kuwabara Y, Tsutsui H, et al. The usefulness of dipyridamole thallium-201 single photon emission computed tomography for predicting perioperative cardiac events in patients undergoing non-cardiac vascular surgery. Ann Nucl Med 2002;16:45-53.
77. Antalffy J, Bajnok L, Kozlovszky B, et al. Estimation of perioperative cardiac risk by means of dipyridamole myocardial scintigraphy in patients undergoing vascular surgery on the lower limbs [in Hungarian]. Orv Hetil 1995;136:703-7.
78. Fleisher LA, Nelson AH, Rosenbaum SH. Failure of negative dipyridamole thallium scans to predict perioperative myocardial ischaemia and infarction. Can J Anaesth 1992;39:179-83.
79. Cutler BS, Leppo JA. Dipyridamole thallium 201 scintigraphy to detect coronary artery disease before abdominal aortic surgery. J Vasc Surg 1987;5:91-100.
80. Patel AD, bo-Aud WS, Davis JM, et al. Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am J Cardiol 2003;92:146-51.
81. Mistry BM, Bastani B, Solomon H, et al. Prognostic value of dipyridamole thallium-201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation. Clin Transplant 1998;12:130-5.
82. Iqbal A, Gibbons RJ, McGoon MD, et al. Noninvasive assessment of cardiac risk in insulin-dependent diabetic patients being evaluated for pancreatic transplantation using thallium-201 myocardial perfusion scintigraphy. Transplant Proc 1991;23:1690-1.
83. Klonaris CN, Bastounis EA, Xiromeritis NC, Balas PE. The predictive value of dipyridamole-thallium scintigraphy for cardiac risk assessment before major vascular surgery. Int Angiol 1998;17:171-8.
84. Lette J, Waters D, Lassonde J, et al. Postoperative myocardial infarction and cardiac death: predictive value of dipyridamole-thallium imaging and five clinical scoring systems based on multifactorial analysis. Ann Surg 1990;211:84-90.
85. Madsen PV, Vissing M, Munck O, Kelbaek H. A comparison of dipyridamole thallium 201 scintigraphy and clinical examination in the determination of cardiac risk before arterial reconstruction. Angiology 1992;43:306-11.
86. Stratmann H, Younis L, Wittry MD, et al. Dipyridamole technetium 99m sestamibi myocardial tomography for preoperative risk stratification before major or minor nonvascular surgery. Am Heart J 1996;536-41.
87. Lane SE, Lewis SM, Pipppin JJ et al. Predictive value of quantitative dipyridamole-thallium scintigraphy in assessing cardiovascular risk after vascular surgery in diabetes mellitus. Am J Cardiol 1989;64:1275-9.
88. Crystal E, Thorpe KE, Connolly SJ, et al. Metoprolol prophylaxis against postoperative atrial fibrillation increases length of hospital stay in patients not on pre-operative beta blocker: Beta blocker Length Of Stay (BLOS) trial. Heart 2004;90:941-2.
89. Rubin BB, Beattie WS. Does coronary artery revascularization before major vascular surgery benefit patients with coronary artery disease? Nature Clin Pract Cardiovasc Med 2005;2:190-1.
90. Stevens RD, Burri H, Tramer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 2003;97:623-33.
91. Auerbach AD, Goldman L Beta-blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA 2002;287:1435-44.
92. Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 2003;114:742-52.
93. Wijeysundera DN, Beattie WS. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth Analg 2003;97:634-41.
94. Beattie WS, Badner NH, Choi P. Epidural analgesia reduces postoperative myocardial infarction: a meta-analysis. Anesth Analg 2001;93:853-8.